1 Bale TL, Vale WW. CRF and CRF receptors: role in stress responsivity and
other behaviors. Annu Rev Pharmacol Toxicol 2004; 44: 525–557.
2 Tache Y, Bonaz B. Corticotropin-releasing factor receptors and stressrelated
alterations of gut motor function. J Clin Invest 2007; 117: 33–40.
3 Florio P, Vale W, Petraglia F. Urocortins in human reproduction. Peptides
2004; 25: 1751–1757.
4 Makrigiannakis A, Zoumakis E, Kalantaridou S, Chrousos G, Gravanis A.
Participation of maternal and fetal CRH in early phases of human
implantation: the role of antalarmin. Curr Drug Targets Immune Endocr
Metabol Disord 2004; 4: 75–78.
5 Grammatopoulos D, Hillhouse EW. Role of corticotropin-releasing hormone
in the onset of labour. Lancet 1999; 353: 1546–1549.
6 Hillhouse EW, Grammatopoulos DK. The molecular mechanisms underlying
the regulation of the biological activity of corticotropin-releasing
hormone receptors: implications for physiology and pathophysiology.
Endocr Rev 2006; 27: 260–286.
7 Chen AM, Perrin MH, Digruccio MR, Vaughan JM, Brar BK, Arias CM,
Lewis KA, Rivier JE, Sawchenko PE, Vale WW. A soluble mouse brain
splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor
binds ligands and modulates their activity. Proc Natl Acad Sci USA
2005; 102: 2620–2625.
8 Wu SV, Yuan PQ, Wang L, Peng YL, Chen CY, Tache Y. Identification and
characterization of multiple corticotropin-releasing factor type 2 receptor
isoforms in the rat esophagus. Endocrinology 2007; 148: 1675–
1687.
9 Grino M, Chrousos GP, Margioris AN. The corticotropin releasing hormone
gene is expressed in human placenta. Biochem Biophys Res Commun
1987; 148: 1208–1214.
10 Smith R. Parturition. N Engl J Med 2007; 356: 271–283.
11 Petraglia F, Potter E, Cameron VA, Sutton S, Behan DP, Woods RJ,
Sawchenko PE, Lowry PJ, Vale W. Corticotropin-releasing factor-binding
protein is produced by human placenta and intrauterine tissues.
J Clin Endocrinol Metab 1993; 77: 919–924.
12 McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental
clock controlling the length of human pregnancy. Nat Med 1995; 1:
460–463.
13 Mastorakos G, Ilias I. Maternal and fetal hypothalamic-pituitary-adrenal
axes during pregnancy and postpartum. Ann NY Acad Sci 2003; 997:
136–149.
14 Simoncini T, Apa R, Reis FM, Miceli F, Stomati M, Driul L, Lanzone A,
Genazzani AR, Petraglia F. Human umbilical vein endothelial cells: a new
source and potential target for corticotropin-releasing factor. J Clin
Endocrinol Metab 1999; 84: 2802–2806.
15 Perkins AV, Linton EA, Eben F, Simpson J, Wolfe CD, Redman CW. Corticotropin-
releasing hormone and corticotropin-releasing hormone binding
protein in normal and pre-eclamptic human pregnancies. Br J Obstet
Gynaecol 1995; 102: 118–122.
16 Karalis K, Goodwin G, Majzoub JA. Cortisol blockade of progesterone: a
possible molecular mechanism involved in the initiation of human labor.
Nat Med 1996; 2: 556–560.
17 Florio P, Lowry PJ, Benedetto C, Galleri L, Torricelli M, Giovannelli A, Battista
R, Reis FM, Petraglia F. Maternal plasma corticotropin-releasing
factor (CRF) and CRF-binding protein (CRF-BP) levels in post-term pregnancy:
effect of prostaglandin administration. Eur J Endocrinol 2007;
157: 279–284.
18 Grammatopoulos DK. The role of CRH receptors and their agonists in
myometrial contractility and quiescence during pregnancy and labour.
Front Biosci 2007; 12: 561–571.
19 Sirianni R, Mayhew BA, Carr BR, Parker CR Jr, Rainey WE. Corticotropinreleasing
hormone (CRH) and urocortin act through type 1 CRH receptors
to stimulate dehydroepiandrosterone sulfate production in human
fetal adrenal cells. J Clin Endocrinol Metab 2005; 90: 5393–5400.
20 Rehman KS, Sirianni R, Parker CR Jr, Rainey WE, Carr BR. The regulation
of adrenocorticotrophic hormone receptor by corticotropin-releasing
hormone in human fetal adrenal definitive ⁄ transitional zone cells.
Reprod Sci 2007; 14: 578–587.
21 Wadhwa PD, Culhane JF, Rauh V, Barve SS. Stress and preterm birth:
neuroendocrine, immune ⁄ inflammatory, and vascular mechanisms.
Matern Child Health J 2001; 5: 119–125.
22 Florio P, Franchini A, Reis FM, Pezzani I, Ottaviani E, Petraglia F. Human
placenta, chorion, amnion and decidua express different variants of corticotropin-
releasing factor receptor messenger RNA. Placenta 2000; 21:
32–37.
23 Clifton VL, Read MA, Leitch IM, Boura AL, Robinson PJ, Smith R. Corticotropin-
releasing hormone-induced vasodilatation in the human fetal placental
circulation. J Clin Endocrinol Metab 1994; 79: 666–669.
24 Jones SA, Challis JR. Local stimulation of prostaglandin production by
corticotropin-releasing hormone in human fetal membranes and placenta.
Biochem Biophys Res Commun 1989; 159: 192–199.
25 Bamberger AM, Minas V, Kalantaridou SN, Radde J, Sadeghian H, Loning
T, Charalampopoulos I, Brummer J, Wagener C, Bamberger CM, Schulte
HM, Chrousos GP, Makrigiannakis A. Corticotropin-releasing hormonemodulates
human trophoblast invasion through carcinoembryonic antigen-
related cell adhesion molecule-1 regulation. Am J Pathol 2006;
168: 141–150.
26 Li W, Challis JR. Corticotropin-releasing hormone and urocortin induce
secretion of matrix metalloproteinase-9 (MMP-9) without change in tissue
inhibitors of MMP-1 by cultured cells from human placenta and
fetal membranes. J Clin Endocrinol Metab 2005; 90: 6569–6574.
27 Gao L, He P, Sha J, Liu C, Dai L, Hui N, Ni X. Corticotropin-releasing hormone
receptor type 1 and type 2 mediate differential effects on
15-hydroxy prostaglandin dehydrogenase expression in cultured human
chorion trophoblasts. Endocrinology 2007; 148: 3645–3654.
28 McKeown KJ, Challis JR. Regulation of 15-hydroxy prostaglandin dehydrogenase
by corticotropin-releasing hormone through a calcium-dependent
pathway in human chorion trophoblast cells. J Clin Endocrinol
Metab 2003; 88: 1737–1741.
29 Jeschke U, Mylonas I, Richter DU, Hocker I, Briese V, Makrigiannakis A,
Friese K. Regulation of progesterone production in human term trophoblasts
in vitro by CRH, ACTH and cortisol (prednisolone). Arch Gynecol
Obstet 2005; 272: 7–12.
30 Karteris E, Goumenou A, Koumantakis E, Hillhouse EW, Grammatopoulos
D. R8duced expression of corticotropin-releasing hormone receptor type
1a in human preeclamptic and growth restricted placentas. J Clin Endocrinol
Metab 2003; 88: 363–370.
31 Vatish M, Randeva HS, Grammatopoulos DK. Hormonal regulation of
placental nitric oxide and pathogenesis of preeclampsia. Trends Mol Med
2006; 12: 223–233.
32 Keller PA, Kirkwood K, Morgan J, Westcott S, McCluskey A. The prevention
of preterm labour-corticotropin releasing hormone type 1 receptors
as a target for drug design and development. Mini Rev Med Chem
2003; 3: 295–303.
33 Grammatopoulos D, Stirrat GM, Williams SA, Hillhouse EW. The biological
activity of the corticotropin-releasing hormone receptor-adenylate
cyclase complex in human myometrium is reduced at the end of pregnancy.
J Clin Endocrinol Metab 1996; 81: 745–751.
34 Grammatopoulos DK, Hillhouse EW. Basal and interleukin-1beta-stimulated
prostaglandin production from cultured human myometrial cells:
differential regulation by corticotropin-releasing hormone. J Clin Endocrinol
Metab 1999; 84: 2204–2211.
35 Aggelidou E, Hillhouse EW, Grammatopoulos DK. Up-regulation of nitric
oxide synthase and modulation of the guanylate cyclase activity by corticotropin
releasing hormone in cultured human pregnant myometrial
cells. Proc Natl Acad Sci USA 2002; 99: 3300–3305.
36 Mignot TM, Paris B, Carbonne B, Vauge C, Ferre F, Vaiman D. Corticotropin-
releasing hormone effects on human pregnant vs. nonpregnant
myometrium explants estimated from a mathematical model of uterine
contraction. J Appl Physiol 2005; 99: 1157–1163.
37 Europe-Finner GN, Phaneuf S, Tolkovsky AM, Watson SP, Lopez Bernal A.
Down-regulation of G alpha s in human myometrium in term and preterm
labor: a mechanism for parturition. J Clin Endocrinol Metab 1994;
79: 1835–1839.
38 Karteris E, Hillhouse EW, Grammatopoulos DK. Urocortin II is expressed
in human pregnant myometrial cells and regulates myosin light chain
phosphorylation: potential role of the type-2 corticotropin-releasing hormone
receptor in the control of myometrial contractility. Endocrinology
2004; 145: 890–900.
39 Bukowski R, Hankins GD, Saade GR, Anderson GD, Thornton S. Laborassociated
gene expression in the human uterine fundus, lower segment,
and cervix. PLoS Med 2006; 3: e169.
40 Markovic D, Vatish M, Gu M, Slater D, Newton R, Lehnert H, Grammatopoulos
DK. The onset of labour alters corticotropin releasing hormone
type 1 receptor (CRH-R1) variant expression in human myometrium:
putative role of IL-1b. Endocrinology 2007; 148: 3205–3213.
41 Tyson-Capper AJ. Alternative splicing: an important mechanism for
myometrial gene regulation that can be manipulated to target specific
genes associated with preterm labour. BMC Pregnancy Childbirth 2007;
7(Suppl. 1): S13.
42 Markovic D, Papadopoulou N, Teli T, Levine MA, Hillhouse EW, Grammatopoulos
DK. Differential responses of CRH receptor type 1 variants to
PKC phosphorylation. J Pharmacol Exp Ther 2006; 19: 1032–1042.